January 30, 2019
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer’s Disease
Read More
January 30, 2019
An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer’s Dementia
Read More
X